Delivery Order SPE2DB22D3010-SPE2DB24FP1FA
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,368.56 contract is for the supply of Repatha 140 mg/mL SureClick injectors, a specialty cardiovascular medication. The contract has an ultimate completion date of July 5, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,554.76 firm-fixed-price contract covers the supply of Repatha 140 mg/mL SureClick, a specialty medication for cardiovascular health. The contract has an ultimate completion date of September 18, 2024 and was awarded on September 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/ml SureClick injector medication. The $4,165.68 firm-fixed-price delivery order has a completion date of July 14, 2025 and is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The order, valued at $5,164.36, is for the pharmaceutical product Repatha 140 mg/ml SureClick (CLIN 4564590862). The contract is a firm-fixed-price arrangement with a completion date of May 14, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a larger Indefinite Delivery...
- This federal contract award is for the delivery of Repatha (140 mg/mL) SureClick injectors, a specialty medication used to treat cardiovascular conditions. The $1,355.76 delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 28, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,801.33 firm fixed price contract is for the supply of Repatha 140 mg/mL SureClick injectors, a medication used to treat cardiovascular conditions. The contract has a period of performance through March 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,742.10 firm fixed-price contract is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of July 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $7,888.81 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product used in cardiovascular disease management. The contract, awarded on April 24, 2025, with a completion date of April 25, 2025, represents a firm fixed-price transaction with no set-aside designation. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a $1,041.42 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Repatha 140 mg/mL SureClick injection medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,263.15 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick injectors, a cardiovascular medication. The contract has an ultimate completion date of May 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP1FADelivery Order
This is a $4,515.96 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Repatha 140 mg/mL SureClick injectors, a specialty medication used to treat cardiovascular conditions. The contract has a completion date of December 22, 2023 and is a firm fixed-price procurement with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. This delivery order is one of many orders placed under that larger IDC vehicle to efficiently procure essential medications for federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 12/21/23 |